HHS Secretary defends eliminating required health benefits

In an interview with CNN, HHS Secretary Tom Price, MD, continued to defend Republican alternatives to the Affordable Care Act (ACA), calling the American Health Care Act (AHCA) “a significantly better program than the one we currently have.”

The AHCA was pulled before the full House of Representatives could vote on the bill. It had faced opposition from almost all major medical organizations, particularly over the elimination of the ACA’s “essential health benefits” that insurers are required to cover, including hospitalization. When asked by CNN’s Sanjay Gupta, MD, about whether it’s an improvement to allow “skimpy plans” which don’t cover those services, Price said it offers more choices for coverage to those who have chosen to remain uninsured.  

“You’ve got 20 million people in this country who have said, ‘Nonsense. I’m not going to be forced to do what you want me to do because I don’t believe it’s necessary for me,’” Price said.

Price also indicated Republicans will continue working on a ACA replacement, saying that despite the last effort failing to gain the support it needed in the House, “there’s always a ‘Plan B.’”

Watch more of the interview at the link below: 

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.